About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Olmesartan as an add-on to Amlodipine in Hypertension

NCT00220233·5 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Sankyo Pharma Gmbh

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Without antihypertensive pre-treatment mean seated BP greater than 160/100 mmHg
Pre-treatment with amlodipine 5 or 10 mg: mean seated BP greater than or equal to 140/90 mmHg

You may not be if

Secondary hypertension
Any serious disorder which may limit the ability to evaluate the efficacy or safety of the test drugs

The record

StatusCompleted

PhasePhase 3

Taking part632

StartedApr 2005

UpdatedDec 24, 2018

Conditions

Essential Hypertension

Where5

Leipzig, Germany
Sinsheim, Germany
Tann, Germany

Clareo Health | Olmesartan as an add-on to Amlodipine in Hypertension